AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

ALPHA GROWTH PLC

M&A Activity Jul 18, 2018

4991_rns_2018-07-18_36231c41-ab9e-47fb-9d34-5a9e120017d8.html

M&A Activity

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9575U

Alpha Growth PLC

18 July 2018

18 July 2018

Alpha Growth plc

("Alpha", or the "Company")

Acquisition of ALM

Alpha Growth plc (LSE: ALGW), the financial services specialist in the growing Senior Life Settlement ("SLS") asset class is pleased to announce the acquisition of Alpha Longevity Management Limited ("ALM").

The Company has, today, signed an agreement for the acquisition of ALM for total consideration of £1. ALM is incorporated in the British Virgin Islands ("BVI") under company number 1832422 and holds an Investment Business License issued by the BVI Financial Services Commission ("BVI FSC"), which allows the company to arrange, advise and manage investments to qualified investors.

It has the added advantage of also being beneficial for the tax structuring of the Company's operations going forward. The acquisition is conditional, among other items, on obtaining approval by the BVI FSC for a change in control. As part of the consideration Alpha has agreed to assume any liabilities, owed by ALM at the time of the transaction, up to $5,000.

ALM was established by Mr. Gobind Sahney, CEO and Executive Chairman of Alpha. Mr. Sahney is a Director of ALM and also owns the majority of the shares, therefore the Board of Directors decided to establish a separate Investment Committee, which comprised Andrew Dennan, the Independent Non-Executive Director, and Rory Heier the Chief Financial Officer. A value of £1 was considered both fair and reasonable.

Rory Heier, member of the Investment Committee, commented:

"We are really pleased to announce the acquisition of ALM. Whilst the company has yet to commence trading it holds numerous benefits to Alpha going forwards and saves both time and money in incorporating a new company ourselves. In addition, the BVI FSC Investment Manager Licence provides us with a regulated entity that can conduct authorised business which is a key feature in global structured products and enhances the attraction and validity of Alpha's platform and product offering to institutional investors in longevity assets."

For more information, please visit www.algwplc.com or contact the following:

Alpha Growth plc +44 20 3959 8600
Gobind Sahney, Executive Chairman [email protected]
Cassiopeia Services (PR/IR) +44 (0) 7949690338
Stefania Barbaglio [email protected]
Novum Securities Limited (Corporate Broker) +44 (0) 207 399 9400
Colin Rowbury [email protected]

About Alpha Growth plc

Specialist in Longevity Assets

Alpha Growth plc is a financial advisory business providing specialist consultancy, advisory, and supplementary services to institutional and qualified investors globally in the multi-billion dollar market of longevity assets. Building on its well-established network, Alpha Growth has a unique position in the longevity asset services and investment business, as a listed entity with global reach. The Company's strategy is to expand its advisory and business services via acquisitions and joint ventures in the UK and the US to attain commercial scale and provide wholistic solutions to alternative institutional investors who are in need of specialised skills and unique access to deploy their financial resource in longevity assets.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

ACQLDLLFVDFXBBL

Talk to a Data Expert

Have a question? We'll get back to you promptly.